Clinical trials for MITF-related melanoma and renal cell carcinoma predisposition syndrome
6 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- ACTIVE NOT RECRUITINGPhase 2NCT06307431A Study of Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Renal Cell Carcinoma (V940-004).Merck Sharp & Dohme LLC · PI: Medical Director
- RECRUITINGPhase 3NCT05078047Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IOUNICANCER · PI: Gwenaëlle GRAVIS-MESCAM, MD
- ACTIVE NOT RECRUITINGPhase 1NCT04707248A Study of DS-6000a in Subjects With Advanced Renal Cell Carcinoma and Ovarian TumorsDaiichi Sankyo · PI: Global Clinical Leader
- RECRUITINGNCT05785052Biomarkers of Renal CancerBiorek S.R.L. · PI: Francesco Montorsi
- ACTIVE NOT RECRUITINGPhase 1NCT03170960Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsExelixis
- RECRUITINGNCT00001238Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant DisordersNational Cancer Institute (NCI) · PI: W. Marston Linehan, M.D.